Reduction of clinically important low glucose excursions with a long‐term implantable continuous glucose monitoring system in adults with type 1 diabetes prone to hypoglycaemia: the France Adoption Randomized Clinical Trial-Reference-Cited by-同舟云学术

Reduction of clinically important low glucose excursions with a long‐term implantable continuous glucose monitoring system in adults with type 1 diabetes prone to hypoglycaemia: the France Adoption Randomized Clinical Trial

Published:2022-02-07 Issue:5 Volume:24 Page:859-867
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Renard Eric¹^ORCID,Riveline Jean‐Pierre²,Hanaire Hélène³^ORCID,Guerci Bruno⁴,

Affiliation:

1. Department of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, INSERM Clinical Investigation Centre 1411 Institute of Functional Genomics, University of Montpellier, CNRS, INSERM Montpellier France

2. Department of Diabetes and Endocrinology, Lariboisiere University Hospital Assistance Publique ‐ Hôpitaux de Paris, University of Paris, INSERM UMRS‐1138 Paris France

3. Department of Diabetology, Metabolic Diseases and Nutrition Toulouse University Hospital Toulouse France

4. Department of Endocrinology, Diabetology and Nutrition Brabois Hospital and University of Lorraine Vandoeuvre Lès Nancy France

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14644

Reference35 articles.

1. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials

2. Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes

3. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study